Bristol-Myers Squibb
GlaxoSmithKline’s majority-owned HIV business to buy drugs from US rival Bristol-Myers Squibb
18 December 2015
Drugmaker Bristol-Myers Squibb acquires rights to Promedior Inc and its experimental drug PRM-151
01 September 2015
Health ministry seeks compulsory licence for Bristol-Myers' cancer drug
03 April 2014
Bristol-Myers Squibb enters $482-mn Latin American deal with Reckitt Benckiser
12 February 2013
Bristol-Myers Squibb may sell some brands in Mexico, Brazil: report
01 February 2013
AstraZeneca to pay Bristol-Myers Squibb $135 mn more for Amylin drug rights
10 August 2012
Bristol-Myers Squibb launches tender offer for Amylin
12 July 2012
Bristol-Myers Squibb, AstraZeneca expand alliance through Amylin acquisition
30 June 2012
Amylin reportedly rejects Bristol-Myers $3.5-bn bid
30 March 2012
Bristol-Myers to acquire hepatitis C oral drug developer Inhibitex for $2.5 bn
09 January 2012
AstraZeneca - Bristol-Myers to present new data on diabetes drug
27 October 2011
Bristol-Myers Squibb to acquire Amira Pharma in a $475 million deal
22 July 2011
Bristol-Myers Squibb offers 84-% premium to buy ZymoGenetics for $885 million
08 September 2010
AstraZeneca, Bristol-Myers Squibb in diabetes research alliance
01 April 2010
Bristol-Myers to divest Mead Johnson for $7.69 billion
16 November 2009
Sigma acquires Bristol-Myers Sqibb’s brands
07 September 2009
AstraZeneca says its new anti-clotting drug better than Plavix
31 August 2009
Bristol-Myers to acquire biotechnology company Medarex for $2.4 billion
23 July 2009
Bristol-Myers Squibb may acquire minority stake in Irish biotech firm
01 June 2009
Bristol-Myers, Syngene open new R&D facility
24 March 2009
GlaxoSmithKline acquires Bristol-Myers Squibb Pakistan
22 December 2008
Bristol-Myers Squibb, Exelixis to collaborate on two novel cancer molecules
12 December 2008
Eli Lilly to acquire ImClone for $6.5 billion
06 October 2008
Mystery buyer Eli Lilly reported to outbid Bristol-Myers with $6.1 billion for ImClone
04 October 2008
Bristol-Myers Squibb raises bid for ImClone to $4.7 billion
23 September 2008
Bristol-Myers Squibb files IPO registration for Mead Johnson
16 September 2008
ImClone rejects Bristol-Myers Squibb's $4.3 billion bid; cites $6.1 billion fresh offer
10 September 2008
Carl Icahn finds Bristol-Myers' offer for ImClone Systems low
04 August 2008
Bristol-Myers Squibb completes sell-off of ConvaTec to PE firms
04 August 2008
Letter from James M Cornelius to Carl Icahn
31 July 2008
Bristol-Myers Squibb to acquire ImClone Systems for $4.5-billion
31 July 2008
Bristol-Myers Squibb to buy anti-cancer drug maker Kosan Biosciences for $190 million
30 May 2008
Bristol-Myers Squibb sells ConvaTec to PE firms for $4.1 billion
03 May 2008
Bristol-Myers Squibb will cut jobs, close plants, to save $1.5 billion
07 December 2007
Bristol-Myers Squibb likely to cut 4,300 jobs
01 December 2007
Accenture and Bristol-Myers Squibb launch pharmaceutical industry''s first joint centre for pharmacovigilance
14 September 2007
Biocon arm to set up dedicated R&D facility for Bristol-Myers Squibb
14 March 2007
Bristol-Myers Squibb to spin off orthopaedics unit
06 July 2001
 search domain-b